IRIS
SOTA, JURGEN
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.177
NA - Nord America 3.092
AS - Asia 605
AF - Africa 34
SA - Sud America 32
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.947
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.087
GB - Regno Unito 1.031
IE - Irlanda 522
IT - Italia 466
RU - Federazione Russa 348
SE - Svezia 253
CN - Cina 235
SG - Singapore 206
UA - Ucraina 163
FR - Francia 124
DE - Germania 94
FI - Finlandia 68
VN - Vietnam 49
TR - Turchia 36
BE - Belgio 24
IN - India 24
CI - Costa d'Avorio 20
BR - Brasile 19
CZ - Repubblica Ceca 19
PK - Pakistan 18
ES - Italia 13
PL - Polonia 13
NL - Olanda 10
IR - Iran 9
EG - Egitto 7
AU - Australia 6
HK - Hong Kong 6
NP - Nepal 4
PE - Perù 4
RO - Romania 4
AR - Argentina 3
BD - Bangladesh 3
CA - Canada 3
HU - Ungheria 3
LV - Lettonia 3
PT - Portogallo 3
AM - Armenia 2
AT - Austria 2
CO - Colombia 2
EC - Ecuador 2
EE - Estonia 2
ET - Etiopia 2
GR - Grecia 2
KE - Kenya 2
MK - Macedonia 2
RS - Serbia 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
EU - Europa 1
IL - Israele 1
IM - Isola di Man 1
IQ - Iraq 1
JM - Giamaica 1
JP - Giappone 1
KG - Kirghizistan 1
KW - Kuwait 1
LU - Lussemburgo 1
MA - Marocco 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 6.947
Salva come PNG Salva come JPEG
Città #
Southend 965
Dublin 512
Fairfield 404
Ashburn 240
Woodbridge 227
Santa Clara 217
Siena 184
Chandler 178
Menlo Park 176
Houston 160
Wilmington 152
Ann Arbor 150
Singapore 139
Cambridge 138
Seattle 138
Jacksonville 132
Princeton 85
New York 79
Dearborn 60
Helsinki 54
Dong Ket 49
Beijing 48
San Mateo 42
Nanjing 41
Boardman 26
San Diego 25
Milan 24
Moscow 23
Brussels 22
Izmir 22
Abidjan 20
Munich 19
Rome 17
Shanghai 17
Nanchang 16
Florence 14
Guangzhou 13
Hebei 12
Jiaxing 11
Shenyang 11
Washington 11
Jinan 10
Kunming 10
Olomouc 10
Dallas 9
Kraków 9
London 9
Lahore 8
Los Angeles 8
Málaga 8
Norwalk 8
Brno 7
Cagliari 7
Changsha 7
Redwood City 7
San Francisco 7
São Paulo 7
Taizhou 7
Bergamo 6
Catania 6
Lappeenranta 6
Tappahannock 6
Cardiff 5
Duncan 5
Istanbul 5
Livorno 5
Padula 5
Sacramento 5
Tianjin 5
Uzzano 5
Zanjan 5
Edinburgh 4
Fort Worth 4
Frankfurt am Main 4
Islamabad 4
Jhelum 4
Lancaster 4
Lima 4
Modena 4
Nottingham 4
Rio de Janeiro 4
Augusta 3
Bari 3
Cecina 3
Changchun 3
Cipolletti 3
Dhaka 3
Hefei 3
Ipatinga 3
Lisbon 3
Parma 3
Pignone 3
Riga 3
Sunshine Coast 3
Xian 3
Acton 2
Addis Ababa 2
Al Mansurah 2
Alexandria 2
Amsterdam 2
Totale 5.172
Salva come PNG Salva come JPEG
Nome #
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis 268
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 258
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 248
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 234
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 214
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 205
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 203
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 200
Treatment options for periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in children and adults: a narrative review 195
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 194
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 188
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 186
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 182
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 180
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 178
Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature 166
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 156
IL-6 blockade in the management of non-infectious uveitis 154
The eye involvement in monogenic autoinflammatory diseases: Literature review and update 149
The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases 146
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 145
Behçet’s syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 136
Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives 134
Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers 120
Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network 118
Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience 113
Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy 97
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes 95
The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis 92
Anakinra drug retention rate and predictive factors of long-term response in systemic juvenile idiopathic arthritis and adult onset still disease 83
Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations 81
Efficacy of monoclonal anti-tumour necrosis factor-α antibodies in uveitic macular oedema 81
Anti-dense fine speckled 70 antibodies in primary Sjögren's syndrome 76
Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis 76
Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseases 75
The role of biosimilars in uveitis: Long-term real-world outcomes of the switch from original to biosimilar TNF-alpha inhibitors 74
Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis 72
Efficacy and safety of abatacept in a patient with rheumatoid arthritis and concomitant Staphylococcus aureus osteomyelitis 71
Impact of HLA-B51 on uveitis and retinal vasculitis: data from the AIDA International Network Registries on ocular inflammatory disorders 69
Development and implementation of the AIDA international registry for patients with Schnitzler's syndrome 68
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 68
Musculoskeletal manifestations in hereditary periodic fever syndromes 66
The current status of biological treatment for uveitis 61
Clinical profile and evolution of patients with juvenile-onset Behçet's syndrome over a 25-year period: insights from the AIDA network 60
New potential weapons for refractory scleritis in the era of targeted therapy 59
Development and implementation of the AIDA International Registry for patients with Behçet's disease 51
Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry 49
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 49
Axial spondyloarthritis in patients with recurrent fever attacks: data from the AIDA network registry for undifferentiated autoInflammatory diseases (USAIDs) 49
Differential serum levels of interleukin-37 in patients with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) 49
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry 47
Comparing biologic options for the management of Behcet's disease-related uveitis 46
Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis 45
Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF- α Receptor - Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA Network 44
Real-Life Data on the Efficacy of Canakinumab in Patients with Adult-Onset Still's Disease 43
Unfolding dermatologic spectrum of Behçet’s disease in Italy: real-life data from the International AIDA Network Behçet’s disease Registry 35
Efficacy and Safety of Upadacitinib in Rheumatoid Arthritis: Real-Life Experience from a Prospective Longitudinal Multicentric Study 26
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 23
Development and implementation of the AIDA international registry for patients with non-infectious uveitis 23
Effectiveness and Safety of Biosimilars in Pediatric Non-infectious Uveitis: Real-Life Data from the International AIDA Network Uveitis Registry 21
Power and spectral Doppler ultrasound in suspected active sacroiliitis: A comparison with magnetic resonance imaging as gold standard 21
Development and Implementation of the AIDA International Registry for Patients With Undifferentiated Systemic AutoInflammatory Diseases 20
A novel grey scale and Power Doppler ultrasonographic score for idiopathic inflammatory myopathies: Siena Myositis Ultrasound Grading Scale 20
Development and implementation of the AIDA international registry for patients with Still's disease 20
Tocilizumab Vs Methotrexate in a Cohort of Patients Affected by Active GCA: A Comparative Clinical and Ultrasonographic Study 20
Development and implementation of the AIDA International Registry for patients with Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis syndrome 19
Biologic drugs in the treatment of polyarteritis nodosa and deficit of adenosine deaminase 2: a narrative review 18
A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project 18
Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: observational study from the International AIDA Registry 18
Ocular Manifestations in Juvenile Behçet’s Disease: A Registry-Based Analysis from the AIDA Network 18
Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA network registries 17
Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behçet’s Syndrome and Psoriatic Arthritis 17
Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders 16
Empowering patients in the therapeutic decision-making process: a glance into Behçet's syndrome 16
Autoinflammatory diseases and the kidney 16
Efficacy and safety of adalimumab in pediatric non-infectious non-anterior uveitis: real-life experience from the International AIDA Network Uveitis Registry 16
The role of biologic agents in the management of pediatric-onset noninfectious posterior scleritis 16
Role of adalimumab biosimilar in the treatment of non-anterior uveitis associated with Behçet’s syndrome 15
Therapeutic approach to central nervous system involvement of Behçet's disease 15
Efficacy of canakinumab in patients with Still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still’s Disease 15
Canakinumab as first-line biological therapy in Still’s disease and differences between the systemic and the chronic-articular courses: real-life experience from the international AIDA registry 15
The autoinflammatory diseases alliance registry of monogenic autoinflammatory diseases 15
The diagnostic role of pathergy test in patients with Behçet’s disease from the Western Europe 14
Biotechnological agents for patients with tumor necrosis factor receptor associated periodic syndrome—therapeutic outcome and predictors of response: real-life data from the AIDA Network 14
Polidistrectual videocapillaroscopic evaluation in a patient with prolidase deficiency 14
The administration of methotrexate in patients with Still's disease, "real-life" findings from AIDA Network Still Disease Registry 14
Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network 14
Development and implementation of the AIDA international registry for patients with non-infectious scleritis 13
Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission 13
Accrual of organ damage in Behçet’s syndrome: trajectory, associated factors, and impact on patients’ quality of life over a 2-year prospective follow-up study 13
Biologic therapies and small molecules for the management of non-infectious scleritis: a narrative review 12
Still’s disease continuum from childhood to elderly: data from the international AIDA Network Still’s disease registry 11
The reduction of concomitant glucocorticoids dosage following treatment with IL-1 receptor antagonist in adult onset Still’s disease. A systematic review and meta-analysis of observational studies 11
Preliminary data revealing efficacy of Streptococcus salivarius K12 (SSK12) in Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis (PFAPA) syndrome: a multicenter study from the AIDA Network PFAPA syndrome registry 11
Efficacy and safety of tocilizumab in adult-onset Still's disease: real-life experience from the international AIDA registry 11
Off-label use of canakinumab in pediatric rheumatology and rare diseases 11
Effectiveness of TNF-α blockade in the treatment of refractory non-infectious scleritis: a multicentre study 10
Dry eye disease and spondyloarthritis: expanding the spectrum of systemic inflammatory disorders associated with ocular surface disease. Data from the international AIDA Network Spondyloarthritis Registry 10
Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases 9
Systemic auto-inflammatory manifestations in patients with spondyloarthritis 9
Totale 7.289
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.770
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020770 0 0 0 0 60 166 114 133 104 95 41 57
2020/20211.229 127 96 54 75 98 197 63 167 74 116 43 119
2021/2022822 72 112 64 55 45 9 36 32 47 78 104 168
2022/2023804 57 71 132 94 57 153 28 63 72 12 37 28
2023/20241.062 39 24 91 56 32 298 302 55 12 18 48 87
2024/20251.235 289 145 354 151 296 0 0 0 0 0 0 0
Totale 7.312